Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RIPK2 Dictates Insulin Responses to Tyrosine Kinase Inhibitors in Obese Male Mice
Brittany M. Duggan, Joseph F. Cavallari, Kevin P. Foley, et al.
Endocrinology (2020) Vol. 161, Iss. 8
Open Access | Times Cited: 19

Showing 19 citing articles:

Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Stephen E. Gitelman, Brian N. Bundy, Ele Ferrannini, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 8, pp. 502-514
Open Access | Times Cited: 91
Inflammation promotes adipocyte lipolysis via IRE1 kinase
Kevin P. Foley, Yong Chen, Nicole G. Barra, et al.
Journal of Biological Chemistry (2021) Vol. 296, pp. 100440-100440
Open Access | Times Cited: 46
Gefitinib initiates sterile inflammation by promoting IL-1β and HMGB1 release via two distinct mechanisms
Takuya Noguchi, Yuto Sekiguchi, Yuki Kudoh, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 37
Glycaemic abnormalities induced by small molecule tryosine kinase inhibitors: a review
Takudzwa Mugiya, Mamosheledi Mothibe, Andile Khathi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
NOD1: a metabolic modulator
Ruobing Tang, Chunguang Xie, X.L. Zhang
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Microbiota and Nod-like receptors balance inflammation and metabolism during obesity and diabetes
Rodrigo Rodrigues e‐Lacerda, Han Fang, Nazli Robin, et al.
Biomedical Journal (2023) Vol. 46, Iss. 5, pp. 100610-100610
Open Access | Times Cited: 10
A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease
James A. Timmons, Andrew Anighoro, Robert J. Brogan, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 15
RIPK2 inhibitors for disease therapy: Current status and perspectives
Erkang Tian, Changhan Zhou, Shuqi Quan, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115683-115683
Closed Access | Times Cited: 9
INSR and ISR‑1 gene polymorphisms and the susceptibility of essential hypertension: A meta‑analysis
Yan Wang, Jianming Li, Xiang Qin, et al.
Experimental and Therapeutic Medicine (2023) Vol. 25, Iss. 6
Open Access | Times Cited: 8
Peripheral and central regulation of insulin by the intestine and microbiome
Jonathan D. Schertzer, Tony K.T. Lam
AJP Endocrinology and Metabolism (2020) Vol. 320, Iss. 2, pp. E234-E239
Open Access | Times Cited: 20
Drug repurposing in cardiovascular inflammation: Successes, failures, and future opportunities
Laura Elizabeth Chaffey, Annabell Roberti, David R. Greaves
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Tyrosine Kinase Targeting
Mohammad Althubiti
Saudi Journal of Medicine and Medical Sciences (2022) Vol. 10, Iss. 3, pp. 183-191
Open Access | Times Cited: 7
Kinase inhibitors for cancer alter metabolism, blood glucose, and insulin
Brittany M. Duggan, Daniel M. Marko, Raveen Muzaffar, et al.
Journal of Endocrinology (2022)
Open Access | Times Cited: 7
Bruton's tyrosine kinase (BTK) inhibitors alter blood glucose and insulin in obese mice but reduce inflammation independent of BTK.
Darryl Y. Chan, Nicole G. Barra, Han Fang, et al.
AJP Endocrinology and Metabolism (2024) Vol. 327, Iss. 3, pp. E271-E278
Closed Access
The Ubiquitination of RIPK2 is Mediated by Peli3 and Negatively Regulates the Onset of Infectious Osteomyelitis
Lixiang Le, Haojie Shan, Yiwei Lin, et al.
Japanese Journal of Infectious Diseases (2023) Vol. 76, Iss. 4, pp. 240-245
Open Access | Times Cited: 1
Dietary fat differentially modulates the response of bone marrow-derived macrophages to TLR4 and NOD2 agonists
Michael G. Shehat, Madelyn Miller, Ashley N. Calder, et al.
Innate Immunity (2023) Vol. 29, Iss. 6, pp. 122-131
Open Access | Times Cited: 1
Sorafenib decreases glycemia by impairing hepatic glucose metabolism
Jingjing Ma, Fang Sui, Yan Liu, et al.
Endocrine (2022) Vol. 78, Iss. 3, pp. 446-457
Closed Access | Times Cited: 2
Future treatment of Diabetes – Tyrosine Kinase inhibitors
Aakash Kumar S, Snehal S. Patel, Shreya Patel, et al.
Journal of Diabetes & Metabolic Disorders (2022) Vol. 22, Iss. 1, pp. 61-71
Open Access | Times Cited: 2
A graph centrality-based approach for candidate gene prediction for type 1 diabetes
Neelesh Babu Thummadi, E. Vishnu, Eagappan Subbiah, et al.
Immunologic Research (2021) Vol. 69, Iss. 5, pp. 422-428
Closed Access
Page 1

Scroll to top